05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

  • Upload
    rima-gi

  • View
    215

  • Download
    0

Embed Size (px)

Citation preview

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    1/28

    Metabolic effects of insulin and glucag

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    2/28

    Learning objectivesOn completion of the study of this topic the students should be able to;

    Explain the structure of insulin in order to recognize the peptide chains, total numacids present and disulfide bridges

    Outline the synthesis of pre-proinsulin, proinsulin and insulin in the pancreatic be Evaluate the clinical importance of estimation of C peptide to assess the insulin

    ifferentiate the factors that stimulate and inhibit insulin secretion

    Outline the se!uence of mechanisms by "hich glucose stimulates insulin secreti

    #llustrate the orientation of insulin receptor in the target cell membranes$ %ecognbinding site and site of autophosphorylation in the insulin receptor

    Outline the mechanism of action of insulin emphasizing the role of insulin receptoreceptor substrates %'(

    %elate the influence of insulin on transport of glucose into the muscle and adipos

    Evaluate the regulatory effects of insulin on) *lycolysis, *lycogen metabolism, *+entose phosphate path"ay, atty acid biosynthesis, .* synthesis, /ipolysis &b.* in adipose tissues and amino acid metabolism$ .pply this 0no"ledge to pred

    metabolic derangements in insulin deficiency

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    3/28

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    4/28

    Metabolic integration bet"een major tissues

    1etabolism in ma2or tissues- does 3O

    occur in isolation Exchange of substrates bet"een tissues #nsulin 4 glucagon play 0ey roles

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    5/28

    S S

    7 11

    6

    7

    S

    S

    2

    0

    1

    9

    S

    S

    . Chain

    5 C

    #tructure of insulin

    +olypeptide hormone

    'ecreted by 6-cells of islets of /angerhans in the endocrine pa

    Consists of t"o polypeptide chains . 4 5 connected by disulf

    bridges

    . chain- 78 amino acids, 5 chain- 9: amino acids

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    6/28

    Biosy

    insuli

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    7/28

    Biosynthesis of insulin

    C$peptide Essential for proper insulin folding %eleased along "ith insulin into circulation alf-life in plasma is longer than that of insulin . good indicator of insulin production 4 secretion, can be mea

    plasma to assess endogenous insulin secretion

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    8/28

    Regulation of insulin secretion#timulation of insulin secretion

    a$ *lucose) glucagon-li0e protein-8 &*/+-8(, gastric

    inhibitory polypeptide &*#+(, < sensitivity of -cells to glucose

    *# hormones- released from small intestine afteringestion of food

    Cause an anticipatory rise in insulin levels

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    9/28

    McGrawHill Education:Integrative Medical Biochemistry Examination and Board Review, Michael King

    *lucose in blood? en

    cells &*/@-7( ? glyc

    increase in.+? inh

    .+ dependent AB ch&channel is closed for

    ? depolarization ? a

    voltage gated calcium

    Entry of calciuminto

    increase in intracellulausion of insulin conta

    exocytotic vesicles "it

    membrane ? %nsulin

    &lucose$stimulated secretion of insulin

    'ulfonylureas

    GK

    GLP-1, GIP

    [Ca2+]

    '

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    10/28

    %nhibition of insulin secretion

    #nsulin synthesis 4 release decreases due to

    'carcity of dietary fuels

    'tress &eg) vigorous exercise, infections(

    1ediated by epinephrine&released from adrenal med

    Causes mobilization of glucose from liver &glycogenoly

    fatty acids from adipose tissue &lipolysis(

    Overrides the normal glucose-stimulated release of ins

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    11/28

    %nsulin receptor mechanism of action 1embrane-bound

    receptor

    "o subunits

    &extracellular(, t"o 6subunits span themembrane; connectedby disulfide bridges

    subunits bindinsulin

    6 subunits haveintrinsic tyrosine0inase activity, containautophosphorylationsites

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    12/28

    5inding of insulin to subunits activates tyrosine0inase activity phosphorylation of tyrosineresidues of 6 subunits

    #nitiates a cascade of cell-signaling responses

    +hosphorylation of insulinreceptor substrates %'(

    #%' interact "ith othersignaling molecules, bringingabout biological effects ofinsulin

    #nsulin actions terminated bydephosphorylation of receptor

    %nsulin receptor mechanism of action

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    13/28

    Metabolic effects of insulin

    #nsulin has anabolic effects on

    8$ Carbohydrate metabolism

    7$ /ipid metabolism9$ +rotein metabolism

    %nsulin and cellular glucose upta)e

    $#nsulin promotes glucose upta0e by cells, its utilization and

    $#ncreases transport of glucose into s0eletal 4 cardiac musadipose tissue

    $#ncreases the number of glucose transporters on the memthese cells &*/@-D(

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    14/28

    %nsulin$mediated recruitment of glucose transporters (

    to the cell membrane

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    15/28

    %nsulin

    &lucose upta)e

    (adipose- muscle!

    .

    &lycolysis

    .

    &lycogenesis

    (liver- muscle!.

    &luconeogenesi'

    &lycogenolys'

    /M0 shunt

    (liver!.

    Lipogenesis(liver- adipose!

    .

    Lipolysis (adip'

    *pta)e of amino acids

    protein synthesis (most

    tissues!

    .

    0rotein degradation (m

    '

    Metabolic effects of

    insulin (hypoglycemic!

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    16/28

    #nsulin plasma half-life F minutes

    #nsulin bound to receptor is internalized, insulin degradeinsulin-degrading enzyme &liver, 0idney(

    %eceptors may be degraded or recycled to the cell surfa+ime course of insulin actions

    glucose upta0e &"ithin seconds(

    dephosphorylation of 0ey enzymes &minutes to hrs(

    increase in amount of 0ey enzymes &induction; hrs to da

    &l

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    17/28

    &lucagon 7G a$a polypeptide secreted by

    pancreas

    'ynthesized as preproglucagon,

    glucagon by proteolysisRegulation of glucagon secretio

    'timulated by

    /o" plasma glucose &primary sti

    .mino acids &eg) arginine( from a

    Epinephrine &from adrenal medu

    norepinephrine &sympathetic ner

    &lucagon secretion inhibited by Elevated blood glucose and insulin &follo"ing a carbohydrate-

    meal(

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    18/28

    Mechanism of action of

    glucagon (through &$protein

    coupled receptor!

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    19/28

    &lucagon

    &lycolysis.

    &lycogenesis

    (liver!

    .

    &luconeogenesi

    &lycogenolys

    '

    1atty acid synthesis(liver! .

    Lipolysis (adip

    effect

    '

    *pta)e of amino acids by liver for

    gluconeogenesis

    .

    Metabolic effects of glucagon (hyperglycem

    '

    .

    Beta oidation of 1

    )etogenesis (liver!

    % li d l t h i bl d l

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    20/28

    %nsulin and glucagon response to changes in blood glu

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    21/28

    /ormones involved in blood glucose regulatio

    ypoglycemic hormone)decreases blood glucose level

    %nsulin

    3ormal fasting blood glucose level) F:-8:: mgHdl

    yperglycemic horincrease blood gluc &lucagon 4pinephrine Cortisol &ro"th hormon

    3C+/

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    22/28

    %nfluence of other hyperglycemic hormones on blood

    level

    Epinephrine decreases glycogenesis 4 increases glycogenoly

    Cortisol increases gluconeogenesis 4 decreases glucose utilizextrahepatic tissues

    *ro"th hormone decreases glucose upta0e and utilization by

    .C increases cortisol synthesis 4 secretion

    5et effect: raising of blood glucose level

    *lucagon, catecholamines, cortisol 4 * called counterregulat

    hormones

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    23/28

    /ypoglycemia

    /o"er than normal blood glucose level

    Iery critical if blood glucose falls belo" D: mgHd/

    #s a medical emergency &brain re!uires glucose supply frfor its energy metabolism(

    #f transient, can cause cerebral dysfunction

    #f severe 4 prolonged, can cause brain death

    1ultiple mechanisms exist for prevention of or correction

    hypoglycemia

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    24/28

    #ymptoms of hypoglycemia

    .drenergic symptoms &mediated

    by release of catecholamines(

    3euroglycopenia symp

    by impaired delivery ofthe brainanxietypalpitationtremors"eating

    headacheconfusionslurred speech

    seizurescoma 4 death

    .drenergic symptoms occur "hen blood glucose drops abrup 3euroglycopenic symptoms result from a gradual decline in b

    glucose &belo" D: mgHd/(

    &lucoregulatory systems activated by hypoglyce

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    25/28

    &lucoregulatory systems activated by hypoglyce

    #n response ypothal

    glucorec

    release o&by .3'(

    by anteri +ancreat

    release g hese ho

    the hypo

    +ypes of hypoglycemia

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    26/28

    +ypes of hypoglycemia

    8$ #nsulin-induced hypoglycemia

    #n diabetic patients on insulin treatment

    7$ +ost-prandial hypoglycemiaCaused by an exaggerated insulin release after a meal

    9$ asting hypoglycemia) symptoms appear at night or ear

    $ /iver damage

    $ .drenal insufficiency$ .lcohol-induced &refer gluconeogenesis(

    $ #nsulinoma &insulin secreting tumors(

    $ #nborn errors of metabolism

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    27/28

    /ypoglycemia in infants

    Convulsions, tremors, attac0s of apnea

    #nfants born to diabetic mothers

    #ntrauterine malnutrition, prematurity

    *lycogen storage disorders &Eg) Ion *ier0e>s(

    ereditary fructose intolerance

    .drenal insufficiency, hypopituitarismisorders of 6-oxidation &Carnitine deficiency, C+

    deficiency, 1C. deficiency(

    Concept map for

  • 7/25/2019 05.17 Metabolic Effects of Insulin and Glucagon_W2016-2

    28/28

    Concept map for

    metabolic effects

    of insulin

    glucagon